Functional Medicine for Depression in a Primary Care Setting (Recorded Webinar)
-
Register
- User - $10
Many patients with depression do not respond to standard antidepressant treatment even after the addition of second and third antidepressant trials. As standalone therapies, antidepressant medications are likely to be unsuccessful in yielding therapeutic benefits. However, there is a considerable amount of scientific research that supports adjuvant nutritional therapies. This presentation will explore some of the common underlying biological factors precipitating depression. Practical, evidence-based interventions to enhance the efficacy and minimize the side effects of antidepressant medications will be described. Common nutritional deficiencies and their relationship to mental health status will also be discussed in detail. Following the presentation, participants will be able to describe a functional medicine approach to support patients and their families struggling with depression.
Credits: 1.00 contact hours; 0.25 are pharmacology
Expiration Date: June 30th, 2025
$10.00
LEARNING OBJECTIVES
As a result of this activity, the learner will be able to:
- Identify intrinsic and exogenous factors that can cause or contribute to depressive pathogenesis, and understand the mechanisms through which these factors can affect changes in brain function, cognition, and behavior.
- Describe the limitations inherent in traditional symptom -> drug models of depression assessment and treatment, and how a functional approach based upon objective biologic assessment and the ramifications of biochemical individuality can address gaps in extant therapeutic models.
- Elucidate the clinical utility of a functional approach for the treatment of depressive disorders, and how the incorporation of nutritional medicine into extant therapeutic paradigms can coalesce a more complete, patient-centric model of care.
James M. Greenblatt, M.D.
Medical Director
Walden Behavioral Care
A pioneer in the field of integrative medicine, James M. Greenblatt, MD, has treated patients since 1988. After receiving his medical degree and completing his psychiatry residency at George Washington University, Dr. Greenblatt completed a fellowship in child and adolescent psychiatry at Johns Hopkins Medical School. He currently serves as the Chief Medical Officer at Walden Behavioral Care in Waltham, MA and serves as an Assistant Clinical Professor of Psychiatry at Tufts University School of Medicine and Dartmouth College Geisel School of Medicine. Dr. Greenblatt has lectured internationally on the scientific evidence for nutritional interventions in psychiatry and mental illness. He is the author of seven books, including Finally Focused: The Breakthrough Natural Treatment Plan for ADHD. He is the founder of Psychiatry Redefined, an educational platform dedicated to the transformation of psychiatry, which offers online CME-approved courses, webinars, and fellowships for professionals about functional and integrative medicine for mental illness.
CE INFORMATION
Obtain Your Credits
To earn credits for this activity, you must complete all course components in the following order: 1) complete a three-question pre-test; 2) watch the course presentation video; 3) complete the course evaluation; 4) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your profile dashboard transcript for future access.
Designation Statement
NPACE designates this educational activity for a maximum of 1.00 contact hours, of which 0.25 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.
Accreditation Statement
Nurse Practitioner Associates for Continuing Education (NPACE) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).
In addition to ANCC, NPACE is approved as a provider of continuing education in nursing by: the California Board of Registered Nursing, Provider Number CEP8720 and Florida CE Broker #50-1476.
DISCLOSURES
Faculty
Contributing faculty, James M. Greenblatt, M.D., have disclosed the following relevant financial relationships; Consultant for Pure Encapsulations and JayMac Pharmaceuticals.
Planners
All planners and contributors involved in this educational activity have disclosed no relevant financial relationships.
Disclaimer
The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.
Disclosure of Unlabeled Use
This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Commercial Support
There is no commercial support for this activity.